Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short-term outcomes after liver transplantation - A systematic review of the literature and expert panel recommendations.
Uzung YoonJustyna BartoszkoDmitri BezinoverGianni BiancofioreKatherine T ForkinSuehana RahmanMichael SpiroDimitri Aristotle RaptisYoogoo Kangnull nullPublished in: Clinical transplantation (2022)
Q1: A specific blood product transfusion practice is not recommended. (QOE; low | Recommendation; weak). Cell salvage and educational interventions are recommended. (QOE: low | Grade of Recommendation: moderate). Q2: The routine use of antifibrinolytics is not recommended. (QOE; low | Recommendation; weak). Q3: The use of VET is recommended. (QOE; low-moderate | Recommendation; strong). This article is protected by copyright. All rights reserved.